RG108 attenuates acute kidney injury by inhibiting P38 MAPK/FOS and JNK/JUN pathways.
Kong FX, Liu H, Xu T, Li SJ, Li W, Lu H, Ma NN, Wang YL, Shi JH, Yang YR, Wang FL.
Kong FX, et al. Among authors: yang yr.
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113077. doi: 10.1016/j.intimp.2024.113077. Epub 2024 Sep 12.
Int Immunopharmacol. 2024.
PMID: 39265353